Safety aspects of GH replacement

被引:29
作者
Svensson, Johan [1 ]
Bengtsson, Bengt-Ake [1 ]
机构
[1] Sahlgrens Univ Hosp, Res Ctr Endocrinol & Metab, Dept Endocrinol, SE-41345 Gothenburg, Sweden
关键词
GROWTH-HORMONE GH; CARDIOVASCULAR RISK-FACTORS; DEFICIENT ADULTS; LIFE-SPAN; INSULIN SENSITIVITY; BODY-COMPOSITION; FACTOR-I; HYPOPITUITARY PATIENTS; PREMATURE MORTALITY; PITUITARY-ADENOMAS;
D O I
10.1530/EJE-09-0287
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In adults, GH replacement therapy will often be maintained for decades. Owing to the long duration of GH replacement in many adults, it is essential to establish the long-term safety aspects of the treatment. In this review, studies that have investigated the safety profile of long-term GH replacement will be reviewed with an emphasis on studies based on data from the Pfizer International Metabolic Database (KIMS), These studies show that long-term GH replacement in adults is safe and that long-term GH replacement may even improve cardiovascular mortality and morbidity in GH-deficient adults.
引用
收藏
页码:S65 / S74
页数:10
相关论文
共 94 条
  • [1] GH replacement in 1034 growth hormone deficient hypopituitary adults:: demographic and clinical characteristics, dosing and safety
    Abs, R
    Bengtsson, BÅ
    Hernberg-Ståhl, E
    Monson, JP
    Tauber, JP
    Wilton, P
    Wüster, C
    [J]. CLINICAL ENDOCRINOLOGY, 1999, 50 (06) : 703 - 713
  • [2] Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults
    Al-Shoumer, KAS
    Gray, R
    Anyaoku, V
    Hughes, C
    Beshyah, S
    Richmond, W
    Johnston, DG
    [J]. CLINICAL ENDOCRINOLOGY, 1998, 48 (06) : 795 - 802
  • [3] BODY-COMPOSITION, BONE METABOLISM, AND HEART STRUCTURE AND FUNCTION IN GROWTH-HORMONE (GH)DEFICIENT ADULTS BEFORE AND AFTER GH REPLACEMENT THERAPY AT LOW-DOSES
    AMATO, G
    CARELLA, C
    FAZIO, S
    LAMONTAGNA, G
    CITTADINI, A
    SABATINI, D
    MARCIANOMONE, C
    SACCA, L
    BELLASTELLA, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (06) : 1671 - 1676
  • [4] GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence
    Arnold, J. R.
    Arnold, D. F.
    Marland, A.
    Karavitaki, N.
    Wass, J. A. H.
    [J]. CLINICAL ENDOCRINOLOGY, 2009, 70 (03) : 435 - 438
  • [5] Effects of 10 years of growth hormone (GH) replacement therapy in adult GH-deficient men
    Arwert, LI
    Roos, JC
    Lips, P
    Twisk, JWR
    Manoliu, RA
    Drent, ML
    [J]. CLINICAL ENDOCRINOLOGY, 2005, 63 (03) : 310 - 316
  • [6] The effect of hypopituitarism on life expectancy
    Bates, AS
    VantHoff, W
    Jones, PJ
    Clayton, RN
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) : 1169 - 1172
  • [7] Growth hormone replacement therapy is not associated with any increase in mortality
    Bengtsson, BÅ
    Koppeschaar, HPF
    Abs, R
    Bennmarker, H
    Hernberg-Ståhl, E
    Westberg, B
    Wilton, P
    Monson, JP
    Feldt-Rasmussen, U
    Wüster, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) : 4291 - 4292
  • [8] BENGTSSON BA, 1993, J PEDIATR ENDOCRINOL, V6, P73
  • [9] The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults
    Bengtsson, BÅ
    Abs, R
    Bennmarker, H
    Monson, JP
    Feldt-Rasmussen, U
    Hernberg-Ståhl, E
    Westberg, B
    Wilton, P
    Wüster, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) : 3929 - 3935
  • [10] BENGTSSON BA, 2002, GROWTH HORM IGF RES, V12, P302